Iterate your AI models without bottlenecks with reproducible binding and developability in weeks
The challenge
AI-based discovery teams often encounter three problems when bridging the gap from code to biology. Only Twist has the specialized capabilities to solve all three:
Twist connects sequence generation to documented,
model-ready data through an integrated suite of products and services.
Input your sequences from your Gen AI platforms to generate DNA or protein production for wet-lab validation.
Order now
With high-quality datasets, researchers can train and refine their AI models. Validate those models with Twist Express Antibodies and high-throughput characterization services to generate data from sequences in as few as 20 days.
Order nowTwist enables the validation of your AI outputs for thousands of proteins for binding and developability characteristics. Twist offers custom data delivery formats that are benchmarked against clinical antibody controls to ensure high-quality datasets ready for direct use in your AI and machine learning models.
Speak to an expert
With high-quality datasets, researchers can train and refine their AI models. Validate those models with Twist Express Antibodies and high-throughput characterization services to generate data from sequences in as few as 20 days.
Speak to an expertWhether you’re looking for bespoke data configurations or help with MSA contracts, our team is here to help.
Why Twist
Others can only provide binding confirmation. Twist delivers the full developability picture: every data type your AI model needs to train, rank, and advance leads to clinical validation.
Quantitative kinetic profiling across dilution series to confidently rank binders by true affinity (KD).
Validate Your Best Binders on Cells. Get fast, qualitative or quantitative and definitive binding data.
Map competitive binding relationships to identify epitope diversity and guide lead selection.
Benchmark manufacturing feasibility and sample quality by quantifying production yield, monomeric purity (aSEC), and particle sizing and dispersity indices (DLS) against clinically validated control antibodies and VHHs.
Rapidly assess developability by quantifying thermal stability (Tm) , onset of aggregation (Tagg), and particle distribution to help rank order leads.
Detect off-target and polyspecific interactions early to de-risk downstream development.
Plate-based screening correlated to gold-standard HIC and CIC to enable high-throughput, decision-ready insights.
Customizable assay platforms to evaluate functional potency and mechanism of action across multiple cell types.
Tell us where you are in your AI drug discovery journey. Our scientific team will reach out within one business day to discuss how Twist can accelerate your work.
Not for use in diagnostic procedures.
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Genes
Oligo Pools
NGS
Variant Libraries
Antibodies
IVDR Solutions
